OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
June 02, 2019
With an increased focus on the supply chain security of non-cGMP intermediates, companies need to re-emphasize upstream manufacturing.
Continuous manufacturing may offer huge opportunities, but it will not be right for every facility or product.
May 28, 2019
New offering from Catalent targets integrated development and manufacturing of biologic drugs.
By connecting manufacturing processes and logistics technology, GE Healthcare and World Courier look to accelerate the development of advanced therapies.
Expanded controlled substance capabilities enables Particle Sciences to develop and manufacture Schedule I–V drugs.
May 20, 2019
Temporary power, HVAC, and oil-free compressor systems provide flexibility and control for pharmaceutical manufacturing facilities.
Catalent expands gene therapy capabilities with $1.2-billion acquisition of Paragon Bioservices.
May 16, 2019
A CPhI Middle East & Africa (MEA) expert has forecasted a boom in manufacturing in the region and has expectations that within five years some of the industry will be acting as contract manufacturers for the European market.
May 10, 2019
Research Point Global and WuXi Clinical Development Services have revealed that they are to combine and rebrand as a new CRO, WuXi Clinical.
May 09, 2019
Recipharm Inhalation Solutions is an integrated service for inhalation products.